Antagonist for the ETB receptor with a controversial pattern of activity.
Product Details
Alternative Name: | [Cys11-Cys15]-Endothelin-1 (11-21) |
|
Sequence: | H-Cys-Val-Tyr-Phe-Cys-His-Leu-Asp-Ile-Ile-Trp-OH (Disulfide bonds between Cys1-Cys5) |
|
Formula: | C68H92N14O15S2 |
|
MW: | 1409.7 |
|
Quantity: | *Sold as net peptide weight. |
|
Purity: | ≥97% |
|
Shipping: | Ambient Temperature |
|
Long Term Storage: | -20°C |
|
Regulatory Status: | RUO - Research Use Only |
|
Product Literature References
An endothelin B receptor-selective antagonist: IRL 1038, [Cys11- Cys15]- endothelin-1(11-21): Y. Urade, et al.; FEBS Lett.
342, 103 (1994),
Abstract;
Endothelin: progress in pharmacology and physiology: W.G. Haynes, et al.; TIPS
14, 225 (1993), (Review),
Abstract;
A potent and specific agonist, Suc-[Glu9,Ala11,15]-endothelin-1(8-21), IRL 1620, for the ETB receptor: M. Takai, et al.; BBRC
184, 953 (1992),
Abstract;
An endothelin B receptor-selective antagonist: IRL 1038, [Cys11-Cys15]- endothelin-1(11-21) [retracted in: FEBS Lett 1994 Mar 28;342(1):103]: Y. Urade, et al.; FEBS Lett.
311, 12 (1992),
Abstract;